What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial

Background: Depressive disorders affect approximately 280 million globally, with many finding treatments ineffective or limited by side effects. Growing evidence suggests that psychedelic therapies may help alleviate depressive symptoms. Among these, lysergic acid diethylamide (LSD) microdosing show...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, Anna Forsyth, Will Evans, Nicholas R. Hoeh, Frederick Sundram, David Menkes, Suresh Muthukumaraswamy, Lisa Reynolds
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	SAGE Publishing 2025-12-01
סדרה:	Therapeutic Advances in Psychopharmacology
גישה מקוונת:	https://doi.org/10.1177/20451253251396253
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!